EYPT

#2341
EyePoint, Inc. Common Stock
14.3400 USD
-1.24%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
14.3400
14.3400
Rango anual
9.6500
19.0100
Cambio diario
-1.24%
Variación mensual
+6.86%
Variación en los últimos 6 meses
+19.50%
Cambio anual
+19.50%
Cierres anteriores
14.5200
Abrir
14.3400
Bid
Ask
Mínimo
14.3400
High
14.3400
Volumen
94
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.1964 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.76
Relación precio/flujo de caja
0.04

EyePoint Inc

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

Noticias